HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Am J Physiol Lung Cell Mol Physiol 295: L1-L15, 2008. First published May 2, 2008; doi:10.1152/ajplung.90200.2008
1040-0605/08 $8.00

This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 295/1/L1    most recent 90200.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Wright, J. L. Articles by Churg, A. Search for Related Content PubMed PubMed Citation Articles by Wright, J. L. Articles by Churg, A.

INVITED REVIEW

ANIMAL MODELS OF HUMAN LUNG DISEASE

Animal models of chronic obstructive pulmonary disease

¹Department of Pathology, University of British Columbia, Vancouver, British Columbia; and ²Respiratory Division, Royal Victoria Hospital, and Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada

The mechanisms involved in the genesis of chronic obstructive pulmonary disease (COPD) are poorly defined. This area is complicated and difficult to model because COPD consists of four separate anatomic lesions (emphysema, small airway remodeling, pulmonary hypertension, and chronic bronchitis) and a functional lesion, acute exacerbation; moreover, the disease in humans develops over decades. This review discusses the various animal models that have been used to attempt to recreate human COPD and the advantages and disadvantages of each. None of the models reproduces the exact changes seen in humans, but cigarette smoke-induced disease appears to come the closest, and genetically modified animals also, in some instances, shed light on processes that appear to play a role.

chronic obstructive pulmonary disease

This article has been cited by other articles:

				H. S. Deshmukh, A. McLachlan, J. J. Atkinson, W. D. Hardie, T. R. Korfhagen, M. Dietsch, Y. Liu, P. Y. P. Di, S. C. Wesselkamper, M. T. Borchers, et al. Matrix Metalloproteinase-14 Mediates a Phenotypic Shift in the Airways to Increase Mucin Production Am. J. Respir. Crit. Care Med., November 1, 2009; 180(9): 834 - 845. [Abstract] [Full Text] [PDF]

				A. Churg and J. L. Wright Testing Drugs in Animal Models of Cigarette Smoke-induced Chronic Obstructive Pulmonary Disease Proceedings of the ATS, September 15, 2009; 6(6): 550 - 552. [Abstract] [Full Text] [PDF]

				M. Levy, E. Khan, M. Careaga, and T. Goldkorn Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L125 - L133. [Abstract] [Full Text] [PDF]

				M. Suzuki, T. Betsuyaku, Y. Ito, K. Nagai, N. Odajima, C. Moriyama, Y. Nasuhara, and M. Nishimura Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L614 - L623. [Abstract] [Full Text] [PDF]

				A. Churg, S. Zhou, O. Preobrazhenska, H. Tai, R. Wang, and J. L. Wright Expression of Profibrotic Mediators in Small Airways versus Parenchyma after Cigarette Smoke Exposure Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 268 - 276. [Abstract] [Full Text] [PDF]

				Z. Hantos, A. Adamicza, T. Z. Janosi, M. V. Szabari, J. Tolnai, and B. Suki Lung volumes and respiratory mechanics in elastase-induced emphysema in mice J Appl Physiol, December 1, 2008; 105(6): 1864 - 1872. [Abstract] [Full Text] [PDF]